| Cat. No. | 
                Product Name | 
                
                Information | 
            
            
                
            	| PC-21870 | 
                
                	
                		 SP-2-225 
                       
                  	
                    HDAC6 inhibitor 
                 | 
                
                SP-2-225 is a potent, selective HDAC6 inhibitor, improves antitumor immune responses and prevent tumor relapse after radiotherapy. | 
            
            
                
            	| PC-21650 | 
                
                	
                		 Tefinostat 
                       
                  	
                    HDAC inhibitor 
                 | 
                
                Tefinostat (CHR-2845) is a monocyte/macrophage targeted pan histone deacetylase (HDAC) inhibitor, which is cleaved into the active acid CHR-2847 by the intracellular esterase human carboxylesterase-1 (hCE-1). | 
            
            
                
            	| PC-21608 | 
                
                	
                		 CM-444 
                       
                  	
                    HDAC inhibitor 
                 | 
                
                CM-444 is a potent histone deacetylase (HDAC) inhibitor with IC50 of 7/51/18/531 nM for HDAC1/2/3/6 respectively, also inhibits DNMT1 with IC50 of 2160 nM. | 
            
            
                
            	| PC-21607 | 
                
                	
                		 CM-1758 
                       
                  	
                    HDAC inhibitor 
                 | 
                
                CM-1758 is a novel histone deacetylase (HDAC) inhibitor with IC50 of 5 nM and 126 nM for HDAC1 and HDAC6, respectively. | 
            
            
                
            	| PC-21520 | 
                
                	
                		 YSR734 
                       
                  	
                    HDAC inhibitor 
                 | 
                
                YSR734 is a first-in-class covalent HDACs inhibitor with IC50 of 0.109 uM, 0.154 uM and 0.143 uM for HDAC1, HDAC2, and HDAC3, sparing other deacetylases (HDAC4-HDAC10, IC50>10 uM). | 
            
            
                
            	| PC-21394 | 
                
                	
                		 PB118 
                       
                  	
                    HDAC6 inhibitor. 
                 | 
                
                PB118 is a potent, selective HDAC6 inhibitor with IC50 of 5.6 nM, shows >1000 times selectively towards HDAC1, reduces alzheimer's disease neuropathology.  | 
            
            
                
            	| PC-21309 | 
                
                	
                		 KPZ560 
                       
                  	
                    HDAC1/2 inhibitor 
                 | 
                
                KPZ560 is a potent, HDAC1/2-selective inhibitor with IC50 of 12/68 nM, respectively. | 
            
            
                
            	| PC-21304 | 
                
                	
                		 Mz325 
                       
                  	
                    Sirt2/HDAC6 inhibitor 
                 | 
                
                Mz325 is a potent, selective, dual inhibitor of Sirt2/HDAC6 with IC50 of 320/43 nM, respectively. | 
            
            
                
            	| PC-21042 | 
                
                	
                		 KD5170 
                       
                  	
                    Class I /II HDAC inhibitor 
                 | 
                
                KD5170 (KD-5170) is a potent mercaptoketone-based Class I and II-histone deacetylase (HDAC) inhibitor with IC50 of 45 nM in HeLa cell-based histone H3 hyperacetylation assay. | 
            
            
                
            	| PC-72740 | 
                
                	
                		 NN-390 
                       
                  	
                    HDAC6 inhibitor. 
                 | 
                
                NN-390 (NN390) is a potent, selective HDAC6 inhibitor with IC50 of 9.8 nM, >200-550-fold selectivity over other HDAC isoforms. |